Status: Recruiting
Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment
Describe the progression of inflammatory orbitopathy and the biological progression of patients receiving second-line treatment (immunosuppressants, radiotherapy, or biotherapy).
Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-VingtsUpdated: Aug 15, 2025Locations: 9
Eligibility criteria
Patients aged 18 and older with moderate to severe orbitopathy; [+6]
Patients who have undergone bone or fat decompression surgery; [+4]